ПРИМЕНЕНИЕ БИОИМПЕДАНСНОГО МОНИТОРА СОСТАВА ТЕЛА (ВСМ) В КЛИНИЧЕСКОЙ ПРАКТИКЕ У ДИАЛИЗНЫХ БОЛЬНЫХ (ОБЗОР ЛИТЕРАТУРЫ)
https://doi.org/10.24884/1561-6274-2013-17-4-49-57
Аннотация
Адекватный контроль гидратации играет важную роль в лечении диализных больных. Хорошо известно, что хроническая перегрузка жидкостью вызывает гипертензию и гипертрофию левого желудочка, напротив, дегидратация может быть связана с возникновением интрадиализных осложнений. Гипергидратация и дегидратация являются причинами увеличения заболеваемости и смертности у больных на диализе. Точное определение состояния гидратации у диализных больных остается сложной задачей и часто основывается на клинических критериях из-за отсутствия точных измерительных инструментов. Метод биоимпедансной спектроскопии определяет состояние гидратации и состава тела, достоверность которых была подтверждена методами изотопного разведения и другими референтными методами для определения состава тела.
Ключевые слова
Об авторах
Л. Н. Рахматуллина
Северо-Западный государственный медицинский университет им. И.И.Мечникова
Россия
Россия
Кафедра внутренних болезней и нефрологии
195067, Санкт-Петербург, Пискарёвский пр-т, д. 47. Тел.: 89117231143
К. Я. Гуревич
Fresenius Medical Care
Россия
Россия
Список литературы
1. Шишкин АН, Федорова ЮЮ. Интрадиализная гипотония: факторы, ассоциированные с процедурой гемодиализа. Нефрология 2012; 16 (2): 64-68
2. Daugirdas JT. Pathophysiology of dialysis hypotension: an update. Am J Kidney Dis 2001; 38 [Suppl 4]: 11-17
3. Ozkahya M, Toz H, Qzerkan E et al. Impact of blood control on left ventricular hypertrophy in dialysis patients. J Nephrol 2002; 15: 655-660
4. Cocchi R, Degli EE, Fabbri A et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14: 1536–1540
5. Woodrow G, Devine Y, Cullen M, Lindley E. Application of bioelectrical impedance to clinical assessment of body composition in peritoneal dialysis. Perit Dial Int 2007; 27: 496 -502
6. Agarwal R, Andersen MJ, Pratt JH. On the importance of pedal edema in hemodialysis patients. Clin J Am Soc Nephrol 2008; 3: 153–158
7. Бовкун ИВ, Румянцев АШ. Оценка тактики проведения сеанса гемодиализа у больных с разной величиной артериального давления. Нефрология 2006; 10 (3): 62-67
8. Новикова НА, Гендлин ГЕ, Сторожаков ГИ и др. Выживаемость больных хронической терминальной почечной недостаточностью, получающих постоянный амбулаторный перитонеальный диализ. Клиническая нефрология 2010; 4: 26-33
9. Machek P, Jirka T, Moissl U et al. Optimal fluid status assessed with bioimpedance spectroscopy reduces IMES and hospitalisation in hemodialysis patients. Nephrol Dial Transplant plus 2008; 1(Suppl 2): 322
10. Wizemann V, Wabel P, Chamney P et al. The mortality risk of overhydration in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 1574–1579
11. Ляшенко ОА, Корнеев АМ, Гуревич КЯ. Коррекция артериальной гипертензии у больных на программном гемодиализе. Врач 2011; 2: 63-66
12. Ates K, Nergizoglu G, Keven K et al. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 2001; 60: 767–776
13. Brown EA, Davies SJ, Rutherford P et al. Survival of functionally anuric patients on automated peritoneal dialysis: the European APD Outcome Study. J Am Soc Nephrol 2003; 14: 2948-2957.
14. Menon MK, Naimark DM, Bargman JM et al. Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 2001; 16 (11): 2207–2213.
15. Tonbul Z, Altintepe L, Sözlü C et al. The association of peritoneal transport properties with 24-hour blood pressure levels in CAPD patients. Perit Dial Int 2003; 23 (1): 46–52
16. Wong PN, Mak SK, Lo KY et al. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients. Singapore Med J 2004; 45 (11): 520–524
17. Konings CJAM., Kooman JP, Schonck M et al. Fluid status, blood pressure, and cardiovascular abnormalities in patients on peritoneal dialysis. Perit Dial Int 2002; 22: 477 – 487
18. Дудко МЮ, Шутов ЕВ, Капитанов ЕН, Ермоленко ВМ. Влияние нарушений водного баланса на состояние сердечнососудистой системы у больных на заместительной почечной терапии. Нефрология и диализ 2006; 8 (3): 244-249
19. Ляшенко ОА, Гуревич КЯ, Корнеев АМ. Клинические, лабораторные и инструментальные характеристики, ассоциированные с артериальной гипертензией у больных, находящихся на программном гемодиализе. Нефрология 2011; 15 (2): 49-56
20. Ветчинникова ОН, Пронина ВП, Агальцов МВ, Кантария РО. Ремоделирование левого желудочка сердца у больных на перитонеальном диализе. Клиническая нефрология 2012; 1: 21-30
21. Sinha AD, Agarwal R. Can chronic volume overload be recognized and prevented in hemodialysis patients? The pitfalls of the clinical examination in assessing volume status. Semin Dial 2009; 22: 480–482
22. Agarwal R, Alborzi P, Satyan S et al. Dry-weight reduction in hypertensive hemodialysis patients (DRIP): a randomized, controlled trial. Hypertension 2009; 53: 500–507
23. Kayikcioglu M, Tumuklu M, Ozkahya M et al. The benefit of salt restriction in the treatment of end-stage renal disease by haemodialysis. Nephrol Dial Transplant 2009; 24: 956–962
24. Wang X, Axelsson J, Lindholm B, Wang T. Volume status and blood pressure in continuous ambulatory peritoneal dialysis patients. Blood Purif 2005; 23: 373–378
25. Kutlay S, Dincer I, Sengul S et al. The long-term behavior and predictors of left ventricular hypertrophy in hemodialysis patients. Am J Kidney Dis 2006; 47: 485–492
26. Белов ВВ, Ильичева ОЕ. Динамика показателей хронической сердечной недостаточности у больных хронической болезнью почек при почечно-заместительной терапии. Нефрология 2006; 10 (1): 35-39
27. Charra B, Chazot C. Volume control, blood pressure and cardiovascular function. Lessons from hemodialysis treatment. Nephron Physiol 2003; 93: 94–101
28. D’Amico G, Locatelli F. Hypertension in dialysis: pathophysiology and treatment. J Nephrol 2002; 15: 438–445
29. Levin NW. What clinical insights from the early days of dialysis are being overlooked today? Semin Dial 2005; 18: 13–14
30. Saint-Remy A, Krzesinski JM. Optimal blood pressure level and best measurement procedure in hemodialysis patients. Vasc Health Risk Manag 2005; 1: 235–244
31. Li Z, Lacson E, Lowrie EG, Ofsthun N et al. The epidemiology of systolic blood pressure and death risk in hemodialysis patients. Am J Kidney Dis 2006; 48: 606–615
32. Шутов АМ, Мастыков ВЭ, Едигарова ОМ. Использование допплер-эхокардиографии для уточнения «сухого веса» больного на программном гемодиализе. Нефрология 2004; 8(2): 35-39
33. Shoji T, Tsubakihara Y, Fujii M, Imai E. Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients. Kidney Int 2004; 66(3):1212-1220
34. Stegmayr BG. Ultrafiltration and Dry Weight – What are the Cardiovascular Effects? Artif Organs 2003; 27(3): 227 – 229
35. Zucchelli P, Santoro A. Dry weight in hemodialysis: volemic control. Semin Nephrol 2001; 3: 286-290
36. Paniagua R, Amato D, Vonesh E et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized controlled trial. J Am Soc Nephrol 2002; 13:1307–1320
37. Davies SJ, Woodrow G, Donovan K et al. Icodextrin improves fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 2003; 14: 2338–2344
38. Asci G, Ozkahya M, Duman S et al. Volume control associated with better cardiac function in longterm peritoneal dialysis patients. Perit Dial Int 2006; 26:85–88
39. Wong PN, Mak SK, Lo KY, Tong GM, Wong AK. Factors associated with poorly-controlled hypertension in continuous ambulatory peritoneal dialysis patients. Singapore Med J 2004; 45 (11): 520–524
40. Nishimura K, Kamiya Y, Miyamoto K et al. Molecular weight of polydisperse icodextrin effects its oncotic contribution to water transport. J Artif Organs 2008; 11;165-169
41. Lin X, Lin A, Ni Z et al. Daily peritoneal ultrafiltration predicts patient and technique survival in anuric peritoneal dialysis patients. Nephrol Dial Transplant 2010; 25:2322-2327
42. Jansen MA, Termorshuizen F, Korevaar JC et al. Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 2005; 68:1199-1205
43. Van Biesen W, Verbeke F, Devolder I, Vanholder R. The relation between salt, volume, and hypertension: clinical evidence for forgotten but still valid basic physiology. Perit Dial Int 2008; 28: 596–600
44. Van Biesen W, Williams JD, Covic AC et al. Fluid Status in Peritoneal Dialysis Patients: The European Body Composition Monitoring (EuroBCM) Study Cohort. PLoS ONE 2011; 6(2): e17148
45. Davison SN, Jhangri GS, Jindal K, Pannu N. Comparison of volume overload with cycler-assisted versus continuous ambulatory peritoneal dialysis. Clin J Am Soc Nephrol 2009; 4: 1044–1050
46. Huang WH, Chen KH, Hsu CW et al. Residual renal function – one of the factors associated with arterial stiffness in peritoneal dialysis patients: Insight from a retrospective study in 146 peritoneal dialysis patients. Blood Purif 2008; 26: 133-137
47. Wang AY. The John F. Maher Award Recipient Lecture 2006. The “heart” of peritoneal dialysis: residual renal function. Perit Dial Int 2007; 27: 116-124
48. Han SH, Lee SC, Ahn SV et al. Reduced residual renal function is a risk of peritonitis in continuous ambulatory peritoneal dialysis patients. Nephrol Dial Transplant 2007; 22: 2653-2658
49. Chandna SM, Kulinskaya E, Farrington K. A dramatic reduction of normalized protein catabolic rate occurs late in the course of progressive renal insufficiency. Nephrol Dial Transplant 2005; 20: 2130-2138
50. Van Biesen W, Vanholder R, Veys N, Lameire N. Peritoneal dialysis in anuric patients: concerns and cautions. Semin Dial 2002; 15: 305-310
51. Jansen MAM, Hart AAM, Korevaar JC et al. Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002; 62: 1046–1053
52. Davies SJ, Brown EA, Reigel W et al. What is the link between poor ultrafiltration and increased mortality in anuric patients on automated peritoneal dialysis? Analysis of data from EAPOS. Perit Dial Int 2006; 26: 458–465
53. Wiggins KJ, Rumpsfeld M, Hawley CM, O’Shea A et al. Baseline and time-averaged fluid removal affect technique survival in peritoneal dialysis in a non-linear fashion. Nephrology (Carlton) 2007; 12: 218–223
54. Sipahioglu MH, Aybal A, Unal A et al. Patient and technique survival and factors affecting mortality on peritoneal dialysis in Turkey: 12 years’ experience in a single center. Perit Dial Int 2008; 28(3): 238–245
55. Carmona RA, Fontan PM, Naveiro GR et al. Compared time profiles of ultrafiltration, sodium removal, and renal function in incident CAPD and automated peritoneal dialysis patients. Am J Kidney Dis 2004; 44:132-145
56. Davenport A, Willicombe M. Comparison of fluid status in patients treated by different modalities of peritoneal dialysis using multi – frequency bioimpedance. Int J Artif Organs 2009; 32:779-786
57. Pierratos A. Daily nocturnal home hemodialysis. Kidney Int 2004; 65:1975–1986
58. Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23:2965–2971
59. Ozkahya M, Ok E, Toz H et al. Long-termsurvival rates in haemodialysis patients treated with strict volume control. Nephrol Dial Transplant 2006; 21: 3506–3513
60. Fagugli RM, Pasini P, Quintaliani G et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysispatients. Nephrol Dial Transplant 2003;18: 2332–2338
61. Culleton BF, Walsh M, Klarenbach SW et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: A randomized controlled trial. JAMA 2007; 298 (11): 1291–1299
62. Davies S, Carlsson O, Simonsen O et al. The effects of low-sodium peritoneal dialysis fluids on blood pressure, thirst and volume status. Nephrol Dial Transplant 2009; 24: 1609–1617
63. de Paula FM, Peixoto AJ, Pinto LV et al. Clinical consequences of an individualized dialysate sodium prescription in hemodialysis patients. Kidney Int 2004; 66 [Suppl 3]: 1232–1238
64. Kalantar-Zadeh K, Regidor DL, Kovesdy CP et al. Fluid retention is associated with cardiovascular mortality in patients undergoing long-term hemodialysis. Circulation 2009;119: 671-679
65. Родин И.Н. Инструментальное определение «сухого веса» и оптимального объема ультрафильтрации у больных в условиях лечения программным гемодиализом. Нефрология и диализ 2002; 4(1): 41-44
66. Zhu F, Wystrychowski G, Kitzler T et al. Application of bioimpedance techniques to peritoneal dialysis. Contrib Nephrol 2006; 150: 119–128
67. Devolder I, Verleysen A, Vijt D et al. Body composition, hydration, and related parameters in hemodialysis versus peritoneal dialysis patients. Perit Dial Int 2010; 30:1-7
68. Мартиросов ЭГ, Николаев ДВ, Руднев СГ. Технологии и методы определения состава тела человека. Наука, М., 2006; 102-127
69. Николаев ДВ, Смирнов АВ, Бобринская ИГ, Руднев СГ. Глава 2. Биоимпеданс и его измерение. В: Биоимпедансный анализ состава тела человека. Наука, М., 2009; 49-89
70. Moissl UM, Wabel P, Chamney PW et al. Body fluid volume determination via body composition spectroscopy in health and disease. Physiol Meas 2006; 27: 921–933
71. Chamney PW, Wabel P, Moissl UM et al. A whole-body model to distinguish excess fluid from the hydration of major body tissues. Am J Clin Nutr 2007; 85: 80–89
72. Moissl U, Bosaeus I, Lemmey A et al. Validation of a 3C model for determination of body fat mass. J Am Soc Nephrol 2007; 18 A: 257
73. Moissl U, Wabel P, Chamney PW et al. Validation of a bio impedance spectroscopy method for the assessment of fat free mass. NDT Plus 2008; 1(Suppl 2): 215
74. Wabel P, Chamney PW, Moissl U et al. Reproducibility of bioimpedance spectroscopy (BIS) in health and disease (abstract). Nephrol Dial Transplant 2007; 22 [Suppl 6]: 137
75. Wabel P, Chamney P, Moissl U, Jirka T. Importance of whole-body bioimpedance spectroscopy for the management of fluid balance. Blood Purif 2009; 27: 75-80
76. Passauer J, Miller H, Schleser A et al. Evaluation of clinical dry weight assessment in haemodialysis patients by bioimpedance spectroscopy. J Am Soc Nephrol 2007; 18 A: 256
77. Wizemann V, Rode C, Wabel P. Whole-body spectroscopy (BCM) in the assessment of normovolemia in hemodialysis patients. Contrib Nephrol 2008; 161: 115–118
78. Wabel P, Moissl U, Chamney P et al. Towards improved cardiovascular management: the necessity of combining blood pressure and fluid overload. Nephrol Dial Transplant 2008; 23: 2965–2971
79. Passauer J, Petrov H, Schleser A. Evaluation of clinical dry weight assessment in haemodialysis patients using bioimpedance spectroscopy: a cross-sectional study. Nephrol Dial Transplant 2009; 1: 1–7
80. Ponce P, Taborsky P, Vlasak J. Assessment and reduction of fluid overload using a body composition monitor. NDT Plus 2009; 2 (4): 335-336
81. Onofriescu M, Mardare NG, Segall L et al. Randomized trial of bioelectrical impedance analysis versus clinical criteria for guiding ultrafiltration in hemodialysis patients: effects on blood pressure, hydration status, and arterial stiffness. Int Urol Nephrol 2012; 44(2): 583-591
82. Tapolyai M, Faludi M, Reti V et al. Dialysis patients fluid overload, antihypertensive medications, and obesity. J ASAIO 2011; 57(6): 511-515
83. Machek P, Jirka T, Moissl U et al. Guided optimization of fluid status in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 538–544
84. Parmentier SP, Schirutschke H, Schmitt B et al. Influence of peritoneal dialysis solution on measurements of fluid status by bioimpedance spectroscopy (abstract). Int Urol Nephrol 2012; http://www.springerlink.com/content/2v08u83q00u62t18/
85. Rosina J, Vranova J, Remes O et al. Bioimpedance Spectroscopy as a noninvasive method of determination of the hydration status in hemodialysis patients. Acta Mechanica Slovaca 2010; 14 (2): 72-77
86. Cheriex E, Leunissen K, Janssen J et al. Echography of the inferior vena cava is a simple and reliable tool for estimation of «dry weight» in hemodialysis patients. Nephrol Dial Transplant 1989; 4: 563–568
87. Hur E, Gungor O, Musayev O et al. Bioimpedance spectroscopy for the detection of hypervolemia in peritoneal dialysis patients. Adv Perit Dial 2011; 27: 65-70
88. Sipahi S, Hur E, Demirtas S et al. Body composition monitor measurement technique for the detection of volume status in peritoneal dialysis patients: the effect of abdominal fullness. Int Urol Nephrol 2011; 43(4):1195-1199
Рецензия
Для цитирования:
Рахматуллина Л.Н., Гуревич К.Я. ПРИМЕНЕНИЕ БИОИМПЕДАНСНОГО МОНИТОРА СОСТАВА ТЕЛА (ВСМ) В КЛИНИЧЕСКОЙ ПРАКТИКЕ У ДИАЛИЗНЫХ БОЛЬНЫХ (ОБЗОР ЛИТЕРАТУРЫ). Нефрология. 2013;17(4):49-57. https://doi.org/10.24884/1561-6274-2013-17-4-49-57
For citation:
Rakhmatullina L.N., Gurevich K.Y. APPLICATION BIOIMPEDANCE BODY COMPOSITION МОNITOR (BCM) IN CLINICAL PRACTICE IN DIALYSIS PATIENTS (LITERATURE REVIEW). Nephrology (Saint-Petersburg). 2013;17(4):49-57. (In Russ.) https://doi.org/10.24884/1561-6274-2013-17-4-49-57
Просмотров:
543
Послать статью по эл. почте 